Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Relationship Between Neurotransmitter Receptor Polymorphisms, Plasma Concentrations and Clinical Response to Clozapine
This completed trial examined how neurotransmitter receptor polymorphisms and Clozapine plasma levels relate to clinical response in schizop…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Employment Outcomes After Vocational Training [NA]
This completed clinical trial evaluated employment outcomes after vocational training for individuals with schizophrenia-related disorders a…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: D-Serine Treatment of Negative Symptoms and Cognitive Deficits in Schizophrenia [Phase 3]
This clinical trial update reports a Phase 3 study evaluating D-serine for negative symptoms and cognitive deficits in schizophrenia, with r…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: RISE (Rehabilitation Intervention for People With Schizophrenia in Ethiopia) [NA]
A clinical trial (RISE) evaluating rehabilitation interventions for people with schizophrenia in Ethiopia has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Past Pain Experience and Perception of Experimental Pain
This completed clinical trial investigated how past pain experience relates to perceptions of experimental pain in individuals with schizoph…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable Schizophrenia [Phase 1]
Phase 1 study evaluating TAK-058 and ondansetron on P50 auditory gating in participants with stable schizophrenia; the trial was terminated …
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: The Effects of Nicotine on Cognition in Schizophrenia [Phase 4]
Phase 4 clinical trial update examining the effects of nicotine on cognition in individuals with schizophrenia; results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-27Clinical Trial Update: Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
A six-year follow-up update from a clinical trial studying anomalous self-experience in first-episode psychosis, reporting long-term outcome…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating a community-based management model using long-acting injectable antipsychotics to reduce violence risk in …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging [NA]
A completed Vanderbilt-sponsored clinical trial update describes using fMRI to quantify abnormal cortical activation associated with auditor…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Optimisation of Antipsychotic Drug Use in Older People [Phase 4]
Phase 4 clinical trial update on optimizing antipsychotic use in older people with Alzheimer's disease or schizophrenia; the study has been …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium [Phase 1]
A Phase 1 pilot trial compared xanomeline alone to xanomeline plus trospium in people with schizophrenia and has completed. The study was sp…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Oxytocin Treatment of Schizophrenia [NA]
A completed clinical trial evaluating oxytocin as a treatment for schizophrenia, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism [Phase 2]
Phase 2 trial assessing a treatment to facilitate NMDA receptor function in patients with schizophrenia and co-morbid alcoholism; study comp…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone [Phase 3]
Phase 3 trial evaluating cognitive remediation in schizophrenia or schizoaffective disorder patients stabilized on lurasidone has completed …
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation [Phase 2]
Phase 2 trial evaluating whether omega-3 fatty acid supplementation lowers coronary artery disease risk in people with schizophrenia or schi…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry [Phase 2]
A Phase 2 trial sponsored by Janssen evaluated the clinical utility of measuring antipsychotic medication levels in plasma using LC-MS/MS. T…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia [NA]
A completed clinical trial evaluated the effects of aerobic endurance training and maximal strength training in patients with schizophrenia,…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Study of the Effects of Mecamylamine and Varenicline in Schizophrenia [NA]
A completed clinical trial evaluating the effects of mecamylamine and varenicline on cognition in schizophrenia; results were posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia [Phase 3]
Phase 3 safety and tolerability study of oral OPC-34712 as maintenance treatment in adults with schizophrenia has completed and results were…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Add-on Simvastatin in Schizophrenia Trial [NA]
This update reports on a trial testing add-on simvastatin for schizophrenia, sponsored by the New York State Psychiatric Institute. The tria…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: SB-773812 Administered In Adults With Schizophrenia [Phase 2]
Phase 2 trial of SB-773812 in adults with schizophrenia has completed (status: COMPLETED). GlaxoSmithKline is the sponsor.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Improving Care and Reducing Cost Study [NA]
A completed clinical trial update from Northwell Health. The study aims to improve care and reduce costs for schizophrenia, schizoaffective …
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Antipsychotics and Gene Expression in Soft Tissues [Phase 4]
Phase 4 clinical trial update from Medical University of Vienna investigating antipsychotics and gene expression in soft tissues in schizoph…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Pediatric Schizophrenia Efficacy and Safety Study [Phase 3]
Phase 3 pediatric schizophrenia efficacy and safety trial completed; results were posted in 2017.